share_log
Benzinga ·  04/30 09:19

NRx Pharmaceuticals Shares Are Trading Lower After the Company Announced Findings From Its Phase 2b/3 Trial of NRX-101 Vs. Lurasidone

nRx Pharmicals公布了其 NRX-101 Vs. 2b/3阶段试验的结果后,该公司股价走低卢拉西酮

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发